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Abstract
Elevated intraocular pressure (IOP) is the predominant risk factor for glaucoma, and reduc-
ing IOP is the only successful strategy to prevent further glaucomatous vision loss. IOP is
determined by the balance between the rates of aqueous humour secretion and outflow,
and a pathological reduction in the hydraulic conductance of outflow, known as outflow
facility, is responsible for IOP elevation in glaucoma. Mouse models are often used to
investigate the mechanisms controlling outflow facility, but the diminutive size of the
mouse eye makes measurement of outflow technically challenging. In this study, we pres-
ent a new approach to measure and analyse outflow facility using iPerfusion™, which
incorporates an actuated pressure reservoir, thermal flow sensor, differential pressure
measurement and an automated computerised interface. In enucleated eyes from C57BL/
6J mice, the flow-pressure relationship is highly non-linear and is well represented by an
empirical power law model that describes the pressure dependence of outflow facility. At
zero pressure, the measured flow is indistinguishable from zero, confirming the absence of
any significant pressure independent flow in enucleated eyes. Comparison with the com-
monly used 2-parameter linear outflow model reveals that inappropriate application of a lin-
ear fit to a non-linear flow-pressure relationship introduces considerable errors in the
estimation of outflow facility and leads to the false impression of pressure-independent out-
flow. Data from a population of enucleated eyes from C57BL/6J mice show that outflow
facility is best described by a lognormal distribution, with 6-fold variability between individu-
als, but with relatively tight correlation of facility between fellow eyes. iPerfusion represents
a platform technology to accurately and robustly characterise the flow-pressure relation-
ship in enucleated mouse eyes for the purpose of glaucoma research and with minor modi-
fications, may be applied in vivo to mice, as well as to eyes from other species or different
biofluidic systems.
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Introduction
Intraocular pressure (IOP) is regulated by the balance between the secretion of aqueous
humour (AH) and its outflow across the hydrodynamic resistance of the conventional outflow
pathway. An increase in outflow resistance can lead to ocular hypertension, which is a major
risk factor in glaucoma; a disease for which a reduction of IOP is the sole therapeutic target for
sight preservation [1–3]. The physiology of AH outflow is complex, involving flow through
both the trabecular meshwork and Schlemm’s canal (conventional outflow pathway) and the
ciliary muscle, choroid and sclera (unconventional outflow pathway). Although the conven-
tional pathway is the predominant outflow route in humans and increased resistance of this
pathway is largely responsible for the elevated IOP observed in glaucoma [4], current medical
treatments generally either promote unconventional outflow or reduce AH secretion [5, 6]. An
increasing amount of research is therefore being aimed at developing treatments that target the
root cause of ocular hypertension, namely increased resistance of the conventional outflow
pathway [7, 8].
Mouse eyes are becoming an increasingly popular model for investigating the mechanisms
of outflow and the hydrodynamic conductance of the conventional outflow pathway, known as
outflow facility (the reciprocal of hydrodynamic resistance). Recent studies have shown that
this pathway is anatomically similar in mice to that in human eyes [9, 10] and exhibits a com-
parable pharmacological response to drugs that both increase and decrease outflow facility
[11–14]. In addition, the ability to genetically manipulate mice enables investigation of the
genomic factors that regulate outflow physiology [15–20]. The considerable disadvantage of
mouse eyes is their diminutive size, being approximately 3% of the volume of AH compared to
human eyes [21, 22], which corresponds to extremely low flow rates, on the order of 50 nl/min
at physiological IOP. This makes the assessment of outflow facility extremely sensitive to
uncertainties in the methods of measurement and data analysis.
The present study describes iPerfusion™, a new paradigm for the measurement of outflow
facility by ocular perfusion, incorporating measurement techniques, data analysis and presen-
tation methods. Although the present study focuses on enucleated mouse eyes, the system can
be scaled up for facility measurements in any species, and with minor modifications may be
applied in vivo. To provide context, a brief review of existing techniques is provided in the fol-
lowing section.
Existing techniques to measure outflow facility
The commonly used approach for measuring outflow facility is based on mass conservation of
the flow entering and exiting the eye during an in vivo perfusion according to:
Qin þ Q ¼ C P  Peð Þ þ Q0 ð1Þ
which is known as the modiﬁed Goldmann equation [23]. Qin is the rate of AH secretion, Q is
the ﬂow rate into the eye from the perfusion apparatus and Q0 is the pressure-independent out-
ﬂow. P is the intraocular pressure and Pe is the pressure in the episcleral vessels (into which the
AH drains). In this form, C is the total outﬂow facility, comprising both conventional outﬂow
and any pressure-dependent components of unconventional outﬂow and AH secretion (pseu-
dofacility) [23]. Herein we will use the term ‘facility’ to indicate C, for simplicity. In order to
calculate facility, Q0 and Qin, Pe and C itself are often assumed to be pressure independent
(thereby tacitly assuming a linear Q − P relationship). Under these assumptions, two measure-
ments of P and Q are thus sufﬁcient to estimate the facility according to the two-step perfusion
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protocol [24]:
Clin ¼
QII  QI
PII  PI
ð2Þ
where the subscripts I and II denote measurements at two different pressures, and Clin is a pres-
sure independent facility, based on the assumption of a linear Q − P response. Alternatively,
for the case of enucleated eyes, Qin and Pe are zero, hence Eq 1 reduces to
Q ¼ ClinP þ Q0 ð3Þ
In order to provide a more robust method than using Eq 2, it has become common in
mouse eye perfusions to measure multiple (3–5) points and fit a straight line to the Q − P rela-
tionship, assuming that the facility, given by the slope of the line, Clin, is pressure independent.
The unconventional outflow is sometimes estimated from the intercept using this approach
[11–13, 20, 21, 25], although others note that the validity of the method is questionable [26–
28]. Fitting a straight line to the data to estimate facility is only appropriate if C is independent
of pressure and Q0 has a finite value. The validity of these assumptions in the context of enucle-
ated mouse eyes will be investigated in the present study.
A number of methodologies for assessing the flow rate into mouse eyes from perfusion sys-
tems have been reported in the literature. These may be grouped into (1) syringe pump based
systems, in which the flow into the eye is prescribed and the pressure in the eye measured, (2)
pressure-decay based systems, in which the flow rate and pressure are inferred based on the
change in height of a small diameter fluid reservoir, and (3) constant pressure systems, in
which a large diameter fluid reservoir provides a relatively constant eye pressure and the flow
rate is measured, for example, based on the pressure drop along a capillary tube of known
resistance.
Syringe pump based systems. In these systems, a syringe pump is used to deliver a nomi-
nal flow rate, and the pressure in the eye is monitored. Syringe pumps function via a lead screw
driven by stepper motor, and at the low flow rates required for mouse eye perfusions, the finite
steps may introduce pulsations in the flow. These pulsations are proportional to the square of
the inner diameter of the syringe and the step size, and thus use of appropriately small syringe
sizes and high resolution pumps is critical. The simplest pump based approach is to apply a
constant flow rate and allow the system to naturally reach a steady state pressure for each flow
rate [12], although this may take a very long time (30–40 min) [16]. In order to decrease the
time to reach a stable condition, active control of the flow rate can be used to regulate the mea-
sured pressure, often with a pre-pressurisation stage at each step to further improve the tran-
sient response of the system [11, 16, 21, 25, 29, 30].
In pump based systems, a number of flow or pressure steps are analysed, and a straight line
is fitted to the steady state values. The selection of steady state is often not clearly defined and
is prone to subjectivity, particularly in active control systems. Furthermore, very few studies
using pump based systems to measure outflow facility validate the pump output or elucidate
the control algorithm used to obtain and regulate the desired pressure (in systems with active
control), which complicates verification of the results by other research groups.
Pressure-decay based systems. In pressure-decay based systems, a small diameter (D) res-
ervoir open to atmospheric pressure is used to apply a hydrostatic pressure to the eye. As fluid
flows from the reservoir into the eye, the reservoir height decreases over time, t. In the classic
‘two-step’ perfusion method developed for primates [24], the flow rate is measured based upon
the change of mass,m, of the fluid reservoir, but this would not be suitable for mouse eyes due
to the low flow rates (over a 10 minute period under physiological conditions, the change in
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mass for an average mouse eye would be less than 1mg). Aihara et al. [21], estimated the flow
rate by observing the change in height of the fluid reservoir, hr, and related this value to the vol-
ume perfused into the eye over a certain time period. Camras et al. [31] instead related the pres-
sure gradient (based on a straight line fit to P vs t) to the change in height, so as to estimate a
flow rate. These three approaches are mathematically equivalent and can be written as:
Q ¼ 1
r
dm
dt
¼ pD
2
4
dh
dt
¼ pD
2
4rg
dP
dt
ð4Þ
where ρ is the density of the ﬂuid in the reservoir and g is the gravitational acceleration. In all
three forms of Eq 4 (based on change in weight, height or pressure), the ﬂow rate is inferred
based on the derivative of a measured parameter, generally estimated from two time points.
Consequently, instantaneous measurements of the ﬂow rate are not possible, and the methods
yield only an average value over the evaluated time period, typically on the order of minutes.
Furthermore, as the reservoir height is used to infer both the ﬂow rate and the pressure, a
trade-off exists wherein a higher resolution in measurement of the ﬂow rate, achieved by reduc-
ing D or increasing the time period, is accompanied by a greater change in the applied pressure.
Additional sources of error in these methods include estimation of the height of the reservoir,
non-linearity in the pressure sensor or weight measurement, inaccuracies in speciﬁcation of D
(as the ﬂow rate scales with D2) and evaporation. For these reasons, along with the uncertainty
in differentiating inherently noisy experimental data [32], it is preferential to acquire data on a
parameter that is proportional to the ﬂow rate itself [33].
Constant pressure systems. In constant pressure systems, a reservoir with a large diame-
ter can be used to apply a relatively constant pressure, whilst measuring the flow rate directly.
Typically, the flow rate is calculated based on the pressure drop along a capillary tube of known
diameter, located upstream of the eye, using the Hagen-Poiseuille law. Ethier et al. [33] used a
differential pressure sensor to measure the pressure drop across a 150 μm capillary tube, with a
second pressure sensor to measure the IOP. The pressure drop across a capillary tube is highly
dependent on temperature (water viscosity decreases by more than 30% as temperature
increases from 20 to 37°C,2% per degree), hence in their system Ethier et al. [33] immersed
the capillary tubing in a temperature controlled water bath. The system was tested in the range
of facilities relevant to human eyes (200 nl/min/mmHg). Kee et al. [34] proposed a modified
version of this system in which a number of components added for accuracy were omitted in
the interest of simplicity. They tested their system using rat eyes (C 50 nl/min/mmHg). This
approach has not been adopted for studies in mouse eyes, which have considerably lower facili-
ties (C 5 nl/min/mmHg). In addition to the requirement for temperature regulation and
accurate pressure measurement, a small diameter capillary would be needed to generate an
accurately measurable pressure drop (75 μm or less). From a practical perspective, such small
diameter capillaries are prone to blockages and biofilm formation, which would drastically
alter the hydrodynamic resistance of the tube and hence the estimation of the flow rate.
In the present study, we use a large diameter reservoir and commercially available thermal
flow sensor, which enables direct, repeatable, and accurate measurement of the flow rate. The
flow rate is calculated based on thermal gradients along a capillary tube, induced by a small
heating element. Knowledge of the applied pressure, the resistance of the flow sensor and the
flow rate through the sensor provides redundant information, which can be used to monitor
the functioning of the flow sensor itself (for example, to detect blockages).
In summary, measurements of outflow facility in mice are technically challenging and
extremely sensitive to small errors. Although a number of techniques have been described in
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the literature, none have been sufficiently validated and all have considerable limitations. To
overcome these challenges, we have developed the iPerfusion system.
Methods
iPerfusion comprises hardware, control software, protocol, data analysis and statistical method-
ologies, and graphical representations, that together maximise the scientific value of each eye
perfused. This section is subdivided into data acquisition (including validation of the system)
and statistical analysis.
Data acquisition
Experimental setup. The hardware consists of three main components; an actuated reser-
voir, a thermal flow sensor and a differential pressure transducer (Fig 1a). On either side of the
pressure transducer, a manifold (not shown) is used to control the flow path, in order to switch
between configurations required for sensor calibration and system validation. The pressure
applied to the system is controlled using a 10ml reservoir, filled with water. The reservoir is
coupled to a vertically mounted linear actuator (L35; Nanotec, Germany). The fluid passes
from the actuated reservoir through the flow sensor (SLG64-0075; Sensirion AG, Switzerland),
which comprises a 75 μm diameter glass capillary, onto which two temperature sensing ele-
ments are bonded on either side of a heating element. Based on knowledge of the flow charac-
teristics (Poiseuille) and the heat transfer properties of water, the flow rate can be calculated in
the range −5000 to 5000 nl/min. The pressure difference across the outflow pathway is mea-
sured using a silicon micromachined wet-wet differential pressure transducer (0–50mmHg;
PX409; Omegadyne, USA). Supporting Information 1 (S1 File) provides analysis of the accu-
racy of the flow and pressure sensors. The results show that the uncertainties, in the range
appropriate for mouse eye perfusions, are given by ±4 nl/min and ±0.024mmHg (two standard
deviations (SD)) for the flow and pressure sensors respectively.
The eye is completely submerged in a relatively large volume of phosphate buffered saline
(PBS; 20–40ml), which is regulated at 35 ± 0.5°C. Submersion ensures that the temperature
and hydration of the eye remain constant throughout the experiment. The submersion depth
has no effect on the pressure drop across the outflow pathway for the following reason. As
shown in Fig 1a, hydrostatic pressure acting on the outside of the eye is given by ρghb, where hb
is the submersion depth of the eye. For the case of zero flow into the eye, the pressure inside
the eye is given by ρg(hb + hr), where hr is the height of the reservoir relative to the surface of
the fluid in the eye bath. The difference between the internal and external pressures, is given by
ρghr, which we refer to as the applied pressure, Pa. As the flow sensor consists of a small diame-
ter capillary, it has a hydrodynamic resistance that results in a pressure drop, ΔPq = Q(t)/Cq
across the sensor, in the general case of non-zero flow. The measured pressure in the eye, P(t)
is therefore related to the applied pressure, Pa, according to
P tð Þ ¼ rg hr þ hbð Þ  DPq tð Þ  rghb ¼ Pa  Q tð Þ=Cq ð5Þ
which is independent of submersion depth. Due to its location downstream of the ﬂow sensor,
the wet-wet differential pressure transducer directly measures P(t), and therefore would not
be affected by changes in hb, for example due to evaporation from the heated eye bath or
reservoir.
For the present study, two duplicates of the experimental setup were used, so that both eyes
from a given mouse could be measured simultaneously, eliminating the influence of post-mor-
tem time between paired eyes. The time between enucleation and cannulation was generally
less than 30 minutes.
Measurement of Outflow Facility Using iPerfusion
PLOSONE | DOI:10.1371/journal.pone.0150694 March 7, 2016 5 / 29
Experimental protocol. The basic protocol for each perfusion comprises three sections:
calibration/testing of the system, cannulation of the eye and acclimatisation, and a multi-step
perfusion regimen.
For each day of experiments, the pressure sensor was calibrated using an automated 8-point
calibration with the automated linear actuator, which has a resolution of 1.25 μm per step. Sub-
sequently, the resistance of the flow sensor was measured to ensure that it was blockage free.
Prior to each perfusion, the resistance of a glass capillary of known resistance (comparable to a
mouse eye) was measured to confirm that the system was functioning properly. The perfusion
tubing (downstream of the flow sensor) and needle were then filled with perfusate and the
resistance of the needle was measured before cannulating the eye. Note that, as the fluid in the
system was water, there was a water-perfusate interface in the perfusion tubing. However,
given that the volume of the tubing (2ml) was large compared to the total volume perfused in
an experiment (25μl), neither advection nor diffusion could have altered the perfusate enter-
ing the eye. If any of the readings from the tests were unexpected, for example if the system
time-response was too long or measured resistances were not correct, leaks/bubbles/blockages
were identified and removed before the ocular perfusion commenced.
All animal experiments were done ex vivo in accordance with the Animals (Scientific Proce-
dure) Act with the authority of a UK Home Office project licence (PPL 70/7306). All perfusions
were carried out on 10–14 week old male C57BL/6J (B6) mice (Charles River UK, Ltd.), that
were euthanised via cervical dislocation. All mice were fed ad libitum and housed in clear cages
at 21°C with a 12 hour light-dark cycle (lights on at 7AM).
After enucleation, the eyes were stored in PBS at room temperature to await perfusion. Each
eye was then affixed to a platform inside the heated bath with a small amount of cyanoacrylate
glue (Loctite, UK). An XYZ micromanipulator (World Precision Instruments, USA) was used
to cannulate the eye via the anterior chamber with a 33 gauge needle (Nanofil, World Precision
Instruments, USA) under a stereomicroscope. The control perfusate was DBG: Dulbecco’s
PBS containing divalent cations, supplemented with 5.5mM glucose and passed through a
0.2 μm filter. After cannulation, the bath was filled with PBS to fully immerse the eye and the
Fig 1. The iPerfusion system. (a) Schematic of the experimental setup. Inset shows internal (green), external (red) and resultant (blue) pressures acting on
the eye. Flow (b) and pressure (c) traces from a sample mouse eye perfusion. Red highlighted regions show steady-state periods, over which data were
averaged.
doi:10.1371/journal.pone.0150694.g001
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temperature was raised to 35°C. The applied pressure was held at 9mmHg for a period of 30–
45 minutes to allow the eye to acclimatise to the pressure and temperature environment.
After acclimatisation, a nine-step perfusion protocol was carried out, consisting of applied
pressures of 4.5, 6, 7.5, 9, 10.5, 12, 15, 18 and 21mmHg. A sample perfusion tracing is shown in
Fig 1b and 1c.
In order to avoid a subjective element in the definition of steady state at each pressure step,
a steady state condition was defined and automatically monitored by the perfusion software. A
parameter Γ(t) = Q(t)/P(t) was continuously evaluated and dΓ/dt was estimated by linear
regression over a moving window of 5 minutes. When |dΓ/dt| was continuously less than 0.1
nl/min/mmHg/min for one minute, the system was considered to be at steady state. The mea-
sured flow and pressure were then averaged over the four previous minutes to yield Qj and Pj
respectively, for pressure step j. The red lines in Fig 1b and 1c indicate these averaging periods.
This approach ensures that the measured facility changes by less than 0.4 nl/min/mmHg over
the averaging period. For the eyes in the present study, the median change in facility over the
averaging window was 0.16 nl/min/mmHg.
System validation. In order to ascertain the accuracy of the pressure and flow sensors,
independent tests were carried out and are described in S1 File. A series of in vitro tests were
then carried out to investigate the accuracy of the system in measuring facility (hydrodynamic
conductance). A number of lengths of thick walled borosilicate glass capillaries (CM Scientific,
UK) with inner diameter of 51 ± 5 μm were used to create resistances comparable to the out-
flow resistances measured in mouse eyes. The capillaries were cut to lengths, Lc, of approxi-
mately 50, 100 and 150mm. Additional lengths of 250mm and 350mm were achieved by
adding capillaries in series. For each length of capillary, a 7 step perfusion (steps of 4mmHg
starting at 4mmHg) was carried out three times. For each pressure step j, the uncertainty in
the pressure was negligibly small (see S1 File), and the uncertainty in the flow rate (given as a
variance), s2Q;j, was calculated by adding the variance of the measured ﬂow rate over a 30 sec-
ond window, s2Qave, and the uncertainty of the ﬂow sensor, s
2
Qsens. The value of the hydrody-
namic conductance of each length of capillary, C, was calculated for each test by ﬁtting the
line Q = CP to the Qj and Pj values, using weighted regression with weights deﬁned according
to 1=s2Q;j.
Data based on regression analysis are presented as the mean ± the margin of error at a 95%
confidence level, (ME95), which is defined as the half-width of the 95% confidence interval
(CI). When analysing the variability within a sample, two standard deviations will be reported,
which indicate the range of values in which 95% of the population are expected to lie: we will
refer to this as ‘two-sigma’ herein.
Fig 2 shows the measured C with the 95% CI for each of the repeated experiments at each
capillary length. The red line and thin grey lines show the best fit and 95% confidence bounds,
respectively, to the equation C = 1/(RL Lc+R0), where RL is the resistance per unit length and R0
represents the resistance of the system downstream of the flow sensor. This model is used as
hydrodynamic resistance (the reciprocal of conductance) is proportional to length. The model
was fitted using weighted regression, with weights defined according to 1=s2C , where sC is
assumed to be equivalent to the 68%ME on C. The resistance per unit length was found to be
RL = 0.627 ± 0.029mmHg/μl/min/mm (mean ±ME95), while R0 = 1.50 ± 2.25mmHg/μl/min
was not signiﬁcantly different from zero. To conﬁrm that the system was measuring correct
values in absolute terms, the diameter of the capillary based on Poiseuille ﬂow (at 22°C) was
calculated from RL and its conﬁdence intervals. The predicted diameter was 52.8 ± 0.6μm,
which is within the manufacturer’s speciﬁcation (see above). The root mean square deviation
from the best ﬁt was 0.8 nl/min/mmHg, and thus a conservative estimate of two-sigma for the
Measurement of Outflow Facility Using iPerfusion
PLOSONE | DOI:10.1371/journal.pone.0150694 March 7, 2016 7 / 29
measurement of facility could be given as ±1.6 nl/min/mmHg over the range of facilities rele-
vant for mouse eyes.
These in vitro capillary tests provide a frame of reference to establish that facility measure-
ments can be made accurately and reproducibly within the range appropriate for mouse eyes
using iPerfusion. It must be stressed, however, that the accuracy when measuring outflow facil-
ity in real eyes will not necessarily be the same as that measured with in vitro capillaries. While
some sources of uncertainty overlap, such as the flow rate measurement, the measurement of
biological tissues will inevitably involve additional, and likely greater, uncertainties, such as
those associated with tissue variability and with interfacing mechanical and biological systems.
Statistical analysis
In ocular perfusion studies, statistical analysis is generally carried out using hypothesis testing,
where the statistical significance of an experimental treatment is assessed using, for example,
Student’s two sample t-test (paired or unpaired). However, due to biological variability and the
limitations of any experimental measurement, each data point analysed will have some degree
of uncertainty associated with it. The standard t-test, implicitly assumes that the measurement
uncertainty is equal for all samples. The validity of the statistical analysis can be improved by
accounting for uncertainty in the acquired data. To this end, we have developed a statistical
approach, including the ‘weighted t-test’, a modification of Student’s t-test that includes vari-
able uncertainties between data points.
Here we present an overview of the statistical analysis; a complete description of the mathe-
matics is given in S2 File. Although this approach has been developed for processing eye perfu-
sion data, the weighted t-test is applicable to any statistical analysis in which a t-test might
Fig 2. In vitro validation of the system.Data points show the ‘facility’ (hydraulic conductance) of various
lengths of glass capillary with 95% confidence intervals. The fit in red is a linear relationship between
hydraulic resistance and length, with 95% confidence bounds shown in grey. Deviations from the fit can be
used to estimate the accuracy of facility measurement using iPerfusion.
doi:10.1371/journal.pone.0150694.g002
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normally be used, but in which individual measurement uncertainties differ between cases. The
analysis method additionally provides useful estimates of the sample variability and treatment
effect.
A nomenclature listing all mathematical terms used in the analysis is provided in S3 File.
Statistical distributions. Any parametric statistical analysis requires an assumption of the
underlying probability distribution. In order to use the t-test and many of the tools utilised in
the following analysis, the data should be sampled from a normal distribution. However, as
reviewed by Limpert et al. [35, 36], for many real world applications, a normal distribution is
often not appropriate. We posit that this is also the case for facility, for the following reasons.
For the outflow facility of mouse eyes reported in the literature, the standard deviation is
often of similar magnitude to the mean [17, 20, 21, 31], such that range of facilities for a sample
of mice (the lower limit of which can be estimated as the mean minus two standard deviations),
would predict some very low, unphysiological, facilities according to the normal distribution.
Furthermore, facility is inherently multiplicative, rather than additive (for example, doubling
the resistance for a given flow rate would double the pressure drop across the outflow path-
way). From these points, we conclude that outflow facility should be treated as a lognormally
distributed variable, as will be confirmed in the Results section. Therefore, by analysing the log-
arithm of C, Y = ln(C), we may use statistical tools based on the normal distribution.
Unlike facility, the measured flow rate and pressure data are normally distributed variables,
as uncertainties in these measurements occur due to electrical and external noise. The calcula-
tion of facility will be carried out by fitting a model to the measured flow rate and pressure data
using weighted regression analysis, which requires normally distributed data. However, where
the output of the regression analysis yields a lognormally distributed variable, such as facility,
further consideration is required.
Consider fitting Eq 3 to the measured pressure and flow data, for a given eye, for which the
best estimate of Clin ± sClin would be obtained. If the variable Clin was normally distributed, it
could be described according to Clin ± sClin. However, as discussed, it is not Clin, but Ylin = ln
(Clin) that is normally distributed, and we therefore require Ylin ± sYlin. As ln(Clin − sClin) and ln
(Clin+sClin) are not equidistant from ln(Clin), it is not possible to state ±sYlin as a function of sClin.
Rather than fitting Eq 3, it is possible to directly calculate sYlin from the regression, by fitting the
model
Q ¼ eYlin P þ Q0 ð6Þ
which yields Ylin ± sYlin, where the value of Clin is equal to e
Ylin.
With regards to the Q0 term, it is worth noting that as Q0 can take on negative values, it can-
not be lognormally distributed. It is therefore reasonable to assume that Q0 is normally distrib-
uted, and the values of Q0 ± sQ0 will be appropriate for further analysis.
Sources of uncertainty. There are five sources of uncertainty that contribute to variability
in ocular perfusion measurements. We use the term s2 to indicate an uncertainty in the form of
a sample variance. Variances are used as they may be added to combine sources of uncertainty.
1. Measurement of pressure and flow rate: due to non-linearity, irrepeatability and hysteresis
present in all transducers, each measurement has an associated degree of uncertainty that
should be accounted for in the analysis, s2sens (sensor uncertainty). Additionally, there is a
component of uncertainty due to averaging the signal over a period of time, s2ave (averaging
uncertainty). For the flow measurement (subscript Q), the total uncertainty for each pres-
sure step j, can be calculated according to
s2Q;j ¼ s2Qsens þ s2Qave;j
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For the present system, we found that for the pressure measurements (subscript P) the total
uncertainty s2P;j, is negligibly small (see S1 File). Thus from the raw data we obtain the
steady state values Pj, Qj and the uncertainty in the ﬂow rate, s2Q;j.
2. Fitting a model to the data: the facility is calculated by fitting a model to the flow rate and
pressure data using weighted least-squares regression between Qj and Pj, with the weights
defined as 1=s2Qj . For each eye, i, each of the regression parameters in the model has an asso-
ciated variance based on its confidence interval, s2reg;i (regression uncertainty).
3. Intra-individual variability: when using a paired experimental design, it is generally implic-
itly assumed that in the absence of a treatment, no difference would be observed. However,
in complex measurements, a certain amount of deviation from the ideal case is to be
expected. To quantify this, we introduce the intra-individual variability between contralat-
eral eyes, s2con. This parameter inherently includes both the intrinsic biological variability in
outflow facility between contralateral eyes and the added uncertainty associated with inter-
facing the eye with the perfusion system (cannulation), as numerically these are inseparable.
For a given experimental system and sample population, the value of s2con, can be estimated
by carrying out paired perfusions on untreated contralateral eyes, as described in detail in
the Results section and in S2 File. In order to do this, it is assumed that the total variability
in the difference in facility between the paired eyes, s2dif , is made up of contributions from
the average uncertainty in the regression, s2reg , and s
2
con. Therefore, the intra-individual vari-
ability is given by
s2con ¼ s2dif  2s2reg
where the factor 2 arises due to regression uncertainty from both eyes of each pair. Although
s2con does not numerically affect the outcome of the weighted t-test, knowledge of its value
is necessary for estimating the variability of a given treatment in paired analyses, assists in
the visualisation of uncertainties for pairs of eyes, and is beneﬁcial for understanding the
limitations of a perfusion system.
4. Inter-individual variability: when using an unpaired experimental design there will be a var-
iability in outflow facility between individuals for a given population, s2pop, termed the inter-
individual variability. The value of s2pop can be estimated by calculating the total variance of
measured facilities over a given sample, s2tot, and assuming that it comprises both s
2
pop and
s2reg . The inter-individual variability is then given by
s2pop ¼ s2tot  s2reg
As with the s2con term, this inherently includes an uncertainty associated with interfacing
the eye with the perfusion system.
5. Treatment variability: in experiments where the effect of a treatment is evaluated using
either paired or unpaired analysis, there will be a variability in the efficacy of the treatment,
s2tre. This parameter can be estimated as the difference in the variability between the treated
and control samples. Large values of s2tre imply that the treatment effect varies considerably
between individuals, for example if there are subpopulations of ‘responders’ and ‘non-
responders’. Calculation of very small or negative values of s2tre would indicate that the
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additional uncertainty due to the treatment is negligible compared to the inherent variability
present in untreated eyes. Equations for calculating s2tre are provided in the next section, and
the derivations are presented in S2 File.
Central tendency and measures of spread using weighting. Typically, the arithmetic
mean, standard deviation and standard error on the mean (SEM) are used as measures of the
central tendency and spread of the data. However, these values do not incorporate the variable
uncertainty for each measurement. In order to account for measurement uncertainty and thus
provide improved estimates of the sample statistics, the weighted arithmetic mean (WAM) is
used. To calculate the WAM, each value is weighted relative to the reciprocal variance of the
total uncertainty for each pair or individual eye (see below for details). Thus data points with
large uncertainty contribute less to the weighted average, making the calculation more robust.
The weighted standard error on the mean (WSEM) can be calculated as the square root of the
variance on the WAM, and the square root of the unbiased weighted sample variance gives the
weighted standard deviation (WSD). A brief description is given in the following section, refer
to S2 File for details and derivation.
Paired data: for paired data, we first calculate the difference in the parameter of interest for
each pair, and then calculate the average of the differences. For facility, we must use the log
transform Y = ln(C). The difference for a pair of eyes p is then given by Zp = Y2,p − Y1,p, where
the subscripts 1 and 2 refer to the control and treated eyes respectively. The weight for each Zp
is given by the reciprocal of the total uncertainty for each pair
s2Zp ¼ s2tot;Z þ s2reg;p;1 þ s2reg;p;2  2s2reg
where s2tot;Z is the unweighted variance of Zp. The WAM, Z , can be calculated as the weighted
arithmetic mean of Zp. The variance of Z is s2Z and the unbiased weighted sample variance is s
2
Z .
The treatment variability s2tre is estimated using
s2tre ¼ s2Z  s2con  2s2reg
Unpaired data: for unpaired data, we calculate the averages for each population A and B,
and then calculate the difference between the averages. For each eye, i, the weight is given by the
reciprocal of the total uncertainty for each eye
s2Yi ¼ s2tot þ s2reg;i  s2reg
where s2tot is the unweighted variance of Yi. Y , s
2
Y
and s2Y can then be calculated for each popula-
tion sample. Z is then calculated as the difference between the WAM of the two population
samples, Z ¼ YB  YA. The variance of Z can be calculated by adding the variances from the
two population sample, s2
Z
¼ s2
YA
þ s2
Y B
. The treatment variability s2tre is estimated by assuming
s2pop is equal for both samples, and thus where the treated population sample has a larger vari-
ance, it can be attributed to the treatment, hence:
s2tre ¼ s2YB  s2YA  s2reg;B  s2reg;A
 
using the values of s2reg for each population.
Lognormal variables: for a given population, the variable Y corresponds to the average loga-
rithm of the outﬂow facility (expressed in dimensionless units). As it is preferable to report
results in units of facility, we must take the exponential of Y , yielding the geometric mean,
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C ¼ eY , with s
C
¼ esY . Likewise, sC ¼ esY . Note that the  denotes the use of geometric vari-
ables. When moving from the additive (log) domain, in which we describe Y  sY , into the
multiplicative (linear) domain, the ‘plus or minus’ (±) term no longer applies, and is replaced
by ‘times or divide by’ (×/) [36]. Therefore, Y  sY is expressed as C = sC . Note that when
using2sY , the lognormal equivalent becomes = s2C , as e2sY ¼ ðesY Þ
2 ¼ s2
C
.
For both paired and unpaired data, the variable Z represents the average difference in the
logarithm of the facility, Y. A more intuitive variable is the average fold change given by
D ¼ eZ . This can be described easily for unpaired data wherein, Z ¼ YB  YA. Converting
into the multiplicative domain yields D ¼ eZ ¼ CB=CA, which is the proportional change in
the average facility. Therefore s
D
¼ esZ describes the spread in the estimate of D, and hence
how well the average fold change is known.
Reporting statistical results. For each reported statistic, we provide a weighted mean
(geometric or arithmetic for lognormal or normal variables respectively), along with the 95%
confidence interval on the weighted mean. In addition we provide an indication of the spread
or variability in the population. For discussion of why we report the statistics in this way, please
see S2 File, Section S2–6.
Statistical results for a lognormally distributed variable, such as facility, will be reported as
C =MEC ;95 s
2
pop
 
whereMEC;95 is the margin of error given by the half-width of the 95% conﬁdence interval on
the estimate of C. The conﬁdence interval on C can be calculated as
C=MEC ;95;C
 MEC ;95
 
. The term s2pop corresponds to two-sigma, an estimate of the range
that would encompass 95% of the facility values within the population (s2pop ¼ e2spop ). Note that
the margin of error and two-sigma values are multiplicative.
Statistical results for a normally distributed variable, such as Z, will be reported as
Z MEZ ;95 2streð Þ
where 2stre is two-sigma, gives an estimate of the range that encompasses 95% of the treatment
variability. The proportional change will be reported as
D =MED ;95 s
2
tre
 
In addition to D, it may be preferable to report the average percentage change, given by
ðD  1Þ  100%. The conﬁdence bounds for the percentage change are given by
ðD =MED ;95  1Þ  100% and thus it is not possible to state them in terms of a simple ×/.
This is also the case for the treatment effect. Thus, when reporting a percentage change, we will
provide the conﬁdence interval, and/or the range bounded by two-sigma directly. For example,
a proportional change of D ¼ 1:5 withMED ;95 ¼ 1:1 and s2tre ¼ 1:25 could be reported as a
50% increase, with conﬁdence interval [36,65%] and a treatment effect between 20% and 88%.
Hypothesis testing. Student’s t-test yields a p-value, which is an estimate of the probability
that the null hypothesis (Z ¼ 0) is true, based on a t-statistic and an estimate of the number of
degrees of freedom, ν. The ‘weighted t-test’ described in S2 File is similar but incorporates
uncertainties by calculating the t-statistic as the ratio of the weighted mean to the square root
of its weighted variance, t ¼ Z=sZ . Due to the weighting of each data point, ν will be less than
that normally used in a standard t-test (for example ψ − 1 for a paired t-test with ψ pairs). For
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the weighted statistics used in this study, ν can be approximated using the Welch-Satterthwaite
equation (see S2 File for details).
Selection criteria. Three stages of selection criteria must be passed in order for a given
perfusion to be included in further analysis. These approaches were designed to be as robust
and as objective as possible.
1. A benefit of the iPerfusion system is that it enables continuous monitoring of the pressure
and flow rate throughout the perfusion. Therefore, complications due to a poor cannulation,
such as the cornea blocking the needle or poor sealing around the needle tip, become readily
apparent. Cases in which the tracings deviate significantly from the prototypical tracing
shown in Fig 1b and 1c, were thus excluded from further analysis. This process was carried
out prior to calculating the facility, in order to minimise bias.
2. In response to a step increase in applied pressure, the measured pressure typically displays
an exponential decay-type response, settling to a constant pressure over several minutes. In
some eyes, typically at higher pressures, the applied pressure did not reach an apparent
steady state, but slowly decreased over a longer time. To detect and eliminate these cases,
the time constant of the pressure decay was estimated by fitting a single exponential, and
any pressure trace that varied by more than 0.2mmHg after 6 time constants (at which time
the system should be within 0.3% of its steady state value), was considered not to have a
definable steady state condition. In such cases, the non-steady state pressure step and all
subsequent pressure steps were eliminated from the regression analysis. Cases with fewer
than four stable pressure steps were omitted on the basis of being insufficient for regression
analysis using a model with two free parameters. The median number of pressure steps used
per eye in the present study was 8.
3. For paired data, putative outliers in the observed Z values were identified. A non-parametric
approach was used, whereby the median med(Z) was calculated as a robust estimate of the
central value. The median absolute deviation (MAD)
MAD ¼ 1:4826med jZp med Zð Þj ð7Þ
was used as a robust estimator of the sample standard deviation (the 1.4826 is dependent on
the assumption that the underlying distribution is normal). Outliers were classiﬁed as data
points for which the measured value including the uncertainty exceeded 2.5 MAD from the
median [37]. Thus, data points greater than the median were omitted from the analysis if Zp
minus the regression uncertainty exceeded the median plus 2.5 MAD, and vice versa for
data points below the median. This approach is similar to using 2.5 standard deviations
from the mean, but is more robust by accounting for uncertainties on the measurements
and because the estimates of the median and MAD are relatively insensitive to outliers.
None of the paired measurement in this study that passed the ﬁrst two criteria were classi-
ﬁed as outliers.
Results and Discussion
A power law model for the flow-pressure relationship
Fig 3a shows a sample flow vs. pressure plot (for the same perfusion as the traces shown in
Fig 1b and 1c). The linear fit to the data (Eq 6) with 95% confidence bounds are shown in
blue. The raw data, shown in black, appear to be fairly well represented by the linear fit, aside
from a small systematic deviation. The slope of the line, Clin predicts a facility for this eye of
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Fig 3. Selecting an appropriate model for the flow-pressure relationship. (a) A sample flow-pressure curve for the enucleated mouse eye perfusion
shown in Fig 1b and 1c. Points showmeasured data with 95% confidence intervals. Blue: linear fit (Eq 3), C = 9.1 nl/min/mmHg,Q0 = −27.8 nl/min. Red:
power law (Eq 9), Cr = 5.4 nl/min/mmHg, β = 0.44. Shaded regions show 95% confidence bounds. (b) The facility as calculated by the linear and power law
models. Black markers showQ/P, which is independent of the fit, and green markers show facility as calculated according to Eq 8, (Q −Q0)/P, showing the
large influence of the model on the calculated facility. (c) and (d) show equivalent plots for a more non-linear case. Linear fit, C = 14.2 nl/min/mmHg,Q0 =
−66.2 nl/min. Power law,Cr = 5.4 nl/min/mmHg, β = 0.85.
doi:10.1371/journal.pone.0150694.g003
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9.1 ×/ 1.06 nl/min/mmHg. The other free-parameter in the model, Q0, yields a value of
−27.8 ± 5.7 nl/min. Considering Eq 3, the value of Q0 implies that if the pressure in the eye
were zero, fluid would leave the eye at a rate of 27.8 nl/min. For an in vivo eye, some reverse
flow would be expected due to AH secretion, but AH secretion is expected to be negligible in
an enucleated eye.
In some outflow studies [12, 25], a non-zero value of Q0 was interpreted as ‘unconventional’
or pressure-independent outflow. In an enucleated eye, however, there is no clear physical
mechanism that could generate a pressure-independent outflow. The osmotic driving force for
uveovortex outflow [38], typically associated with pressure-independent outflow, would be
eliminated by severing the ocular blood vessels during enucleation. We thereby posit that the
term Q0 should be identically zero in enucleated eyes. In order to test this hypothesis, we mea-
sured the flow rate at an applied pressure of 0mmHg in six enucleated mouse eyes, following a
standard perfusion. For intraocular pressures of 0.036 ± 0.068mmHg, the average flow rate
was 1.1 ± 6.5 nl/min (WAM ± 2WSD). These values are negligibly different from zero. We thus
propose that any flow-pressure model for enucleated mouse eyes should not include a Q0 term,
such that there is no flow at zero pressure. As a corollary, including a non-zero Q0 term in Eq 3
may introduce errors in the estimation of facility.
To investigate the influence of a non-zero Q0 on the estimation of facility, consider Eq 3
rearranged in terms of facility at the jth pressure step.
Clin;j ¼
Qj  Q0
 
Pj
ð8Þ
The values of Clin,j are represented by the green data points in Fig 3b, with the blue line rep-
resenting the constant value of Clin as predicted by fitting a linear model to the data. Shaded
regions represent the 95% confidence interval on the fit. However, as Q0 = 0 for enucleated
mouse eyes, the facility for the jth pressure step is not given by Eq 8 but rather by Cj = Qj/Pj, as
indicated by the black data points in Fig 3b. At a physiological pressure drop across the outflow
pathway of 8mmHg (represented by the vertical dashed lines), the facility predicted when
including a non-zero Q0 value is almost twice that predicted when Q0 = 0, demonstrating that
the estimation of facility is highly sensitive to assumptions regarding Q0. As illustrated in Fig
3c and 1d, the relative influence of Q0 on the estimate of facility is increased for more non-lin-
ear cases. Note that the absence of a Q0 term in enucleated eyes does not negate the presence of
unconventional (non-trabecular) outflow, but does require that any unconventional outflow
that exists be pressure dependent.
We thus require an alternative to the linear model, which allows both a pressure-dependent
facility and a zero-intercept. We propose a simple power law model:
Q Pð Þ ¼ Cr
P
Pr
 	b
P ð9Þ
where Pr is a reference pressure (deﬁned to be 8mmHg), at which Cr is the facility. Following
Eq 6, the model actually used to ﬁt the measured data is
Q Pð Þ ¼ eYr P
Pr
 	b
P ð10Þ
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where Yr = log(Cr). This ﬁt is shown in red in Fig 3. The facility is given by
C Pð Þ ¼ Cr
P
Pr
 	b
ð11Þ
The power exponent β characterises the non-linearity of the flow-pressure relationship and
can be interpreted as an index of the combined sources of non-linearity affecting the flow-pres-
sure relationship through the outflow pathway. When β = 0, the facility is independent of pres-
sure (C = Cr for all P) and the flow-pressure relationship is entirely linear. For β< 0, the
facility decreases with increasing pressure, as may occur due to collapse of Schlemm’s canal,
which increases outflow resistance with increasing IOP [39, 40]. For β> 0, the facility increases
with increasing pressure. Evidence suggests that ‘anterior chamber deepening’ may artificially
increase outflow facility as IOP increases by applying traction to the trabecular meshwork [41].
Anterior chamber deepening typically occurs during ocular perfusion via the anterior chamber,
whenever the pressure in the anterior chamber exceeds that in the posterior chamber [42].
For the case shown in Fig 3a and 3b, Cr = 5.4
×/ 1.04 nl/min/mmHg and β = 0.44 ± 0.06,
which represents a modest non-linearity. Recall that for this case the linear model predicted
Clin = 9.1
×/ 1.06 nl/min/mmHg. For the more non-linear case shown in Fig 3c and 3d,
β = 0.85 ± 0.16 and Cr = 5.4
×/ 1.12 nl/min/mmHg. For this case, the linear model predicts
Clin = 14.2
×/ 1.13 nl/min/mmHg, which is almost three times the facility estimated by the
power law model at physiological pressure drop.
In summary, our data reveal that the flow-pressure relationship is non-linear in enucleated
mouse eyes and can be represented by a power law model that captures the pressure-depen-
dence of outflow facility. Ignoring this non-linearity and fitting a linear flow-pressure relation-
ship to the data introduces an error in the estimation of outflow facility, even when the non-
linearity appears rather subtle as in the case of Fig 3a. This underscores the importance of spec-
ifying an appropriate model to interpret flow-pressure data and to estimate outflow facility.
Comparison of regression parameters for the power law and linear
models
In order to assess the power-law model and compare it to the commonly used linear model
over a population of eyes, we evaluated the regression parameters from 66 independent,
untreated eyes perfused with DBG. For each eye, the data were fit to both the linear and power
law models.
As shown in Fig 4a, no correlation was observed between β and ln(Cr), indicating that the
regression parameters were independent of one another for the power law model. For the linear
model, however, there was a strong correlation between ln(Clin) and Q0 (p< 10
−6; Fig 4b),
where larger negative values of Q0 coincide with larger positive values of ln(Clin). Based on cur-
rent understanding of AH dynamics, there is no physiological precedent for a relationship
between pressure-independent outflow and outflow facility, suggesting that the observed corre-
lation is a result of insufficiencies in the linear model, rather than a physiological link between
the two parameters. Similarly, there is no reason to suspect a relationship between β and ln(Cr),
and no such relationship was observed using the power law model (Fig 4a).
Fig 4c compares Q0 to β. When the non-linearity of the flow-pressure relationship was neg-
ligible (small β), so was the Q0 value, whereas for highly non-linear cases (large β), larger values
of Q0 were found (p< 10
−6). This suggests that the non-linearity of the flow-pressure relation-
ship introduces an artificial non-zero value of Q0, as demonstrated by the data in Fig 3a and 3c.
As Q0 was negative in all cases, outflow facility as predicted by the linear model, Clin was
consistently overestimated. Fig 4d compares the facility calculated by the two models, showing
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Fig 4. Comparing linear and power-lawmodels.Outer ellipses show 95%CI on each parameter. (a) Power law exponent, β, against the logarithm of
reference facility for the power law model: no correlation is observed (p = 0.49). (b) Pressure independent flow,Q0, against the logarithm of facility for the
linear fit: a strong correlation is observed (p < 10−6), suggesting that the linear model is inappropriate. (c) Pressure-independent flow against power law
exponent: a strong correlation is observed: p < 10−6, indicating that non-zeroQ0 values are a result of the non-linearity in theQ − P relationship. (d)
Comparison between log facility predicted by linear and power law models. Red line shows average over-prediction of103% by the linear model.
doi:10.1371/journal.pone.0150694.g004
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that the linear model overestimated the facility with an average increase of103%, as indicated
by the red line, with a maximum of 268%. The error appears to be relatively systematic, imply-
ing that in studies using the linear model, changes in facility are still measurable; however, the
scatter in the data implies that a larger number of samples would be required to achieve suffi-
cient statistical power, compared to the power law model.
Population distributions
In this section, the population characteristics of the 66 independent B6 mice are investigated.
Fig 5a shows a histogram of the Cr values. The histogram is skewed towards lower values of Cr,
although no mice had a facility below 2.5 nl/min/mmHg, and a number of mice exhibited rela-
tively high facilities. Under the assumption of a lognormal distribution, the reference facility
is best described in terms of the geometric mean and geometric standard deviation, yielding
Cr = 5.89
×/ 1.12(2.50) nl/min/mmHg (mean =ME95ðs2popÞ). Thus approximately 95% of the
eyes measured lie in the range 2.4–14.8 nl/min/mmHg. The red curve in Fig 5a represents the
predicted population distribution based on these values. As shown in the histogram, 3 eyes did
have facilities greater than the upper conﬁdence bound, which for 66 eyes could be expected. At
the lower end of the scale, the distribution rapidly tails off and predicts that very few eyes would
yield facilities below 2 nl/min/mmHg (1 in 109). Using the common assumption of normally
distributed facilities, the population distribution would be described by Cr = 6.61 ± 0.85(7.01)
nl/min/mmHg, as shown in blue in Fig 5a. The normal distribution predicts facilities of less
than 2 nl/min/mmHg in 1 out of 11 mice, and negative facilities in 1 out of 34 B6 mice, as indi-
cated by the blue shaded regions in Fig 5a. As negative facilities cannot exist, and the very low
predicted facilities are not in agreement with the current measurements, Cr cannot be well
described by a normal distribution.
Fig 5. Population distributions of the regression parameters for the power lawmodel. (a) Reference facility Cr: histogram of 66 eyes with overlaid
normal (blue) and lognormal (red) distributions. Shaded blue regions show predicted facilities below 2 nl/min/mmHg and below 0 nl/min/mmHg. (b) β:
histogram from 66 eyes with overlaid normal distribution.
doi:10.1371/journal.pone.0150694.g005
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In order to quantify how well the alternative distributions represent the data, we used the
Shapiro-Wilk test [43], which evaluates the probability that null hypothesis that the data are
sampled from a normal distribution is true for the observed data. Small p-values thus indicate
that the data are unlikely to be sampled from a normal distribution. For the facility, Cr, the Sha-
piro-Wilk test yields p = 2.5 × 10−6. For a lognormally distributed parameter such as Cr, its log-
arithm Y = ln(Cr) should be normally distributed. The Shapiro-Wilk test for ln(Cr) yielded
p = 0.016. The Anderson-Darling test (reported to be the second most powerful normality test
after the Shapiro-Wilk test [43]) yielded similar results. Although the tests both reject the nor-
mality of the ln(Cr) distribution at the standard threshold of p = 0.05, the p-value for ln(Cr) is
significantly larger than for the distribution of Cr, indicating that the lognormal distribution is
a considerable improvement.
The predicted population range in facility is rather large, considering that the mice should
be genetically identical and their environment relatively constant. In order to investigate
whether external factors contributed to the spread of Cr, we examined the relationship between
Cr and a number of possible confounding variables using Pearson’s correlation coefficient, r.
The time of enucleation did not correlate with Cr (r = 0.014), suggesting that diurnal oscilla-
tions do not appear to be a cause of the large range in baseline facilities for the population. The
time between enucleation and cannulation (r = −0.036) and the age of the mouse (r = 0.067)
also showed no correlation with the measured facility. No effect of the day of the week on
which the perfusion was carried out was detected using a one-way ANOVA (p = 0.10).
For the non-linearity parameter, β, the population distribution is shown in Fig 5b. In this
case, the data are reasonably well represented by the normal distribution. The Shapiro-Wilk and
Anderson-Darling tests yielded p = 0.044 and p = 0.086 respectively, indicating that it is reason-
able to assume a normal distribution for this parameter. The distribution of β is described by
β = 0.752 ± 0.079(0.631).
Analysis of paired measurements
Reference facility. The large range of facilities observed in the population highlights the
benefits of using paired analysis, which considerably reduces the parameter space by providing
a contralateral control eye for each treated eye. In paired analyses, it is often tacitly assumed
that if no modification was applied, then the control and experimental cases would yield identi-
cal values; that is the pairs are ‘ideal’. However, with such difficult measurements, and particu-
larly with biological tissue, there will always be an inherent degree of uncertainty, and thus the
extent of the ‘pairedness’ should be considered. In order to analyse the intra-individual vari-
ability between untreated contralateral eyes,Ccon = 10 pairs of eyes were perfused simulta-
neously with DBG on duplicate systems.
For each pair, p, the value of Zp (the difference in the log-transformed facility between the
treated and control eye) was calculated. Fig 6a shows a ‘paired facility plot’ for the data. The
x and y-axes are the log-transformed facility of the two contralateral eyes, therefore each pair
yields a single point on the graph, with the blue ellipses indicating the 95% confidence intervals
based on the output of the weighted regression fit of Eq 9. It can be seen that, even when
accounting for the confidence intervals from the regression, not all data points overlap the
unity line (shown in blue), which would indicate a measurement that is equal for both
untreated eyes. Therefore, an additional source of uncertainty must exist, which can be attrib-
uted to the intra-individual variability, s2con.
In order to estimate s2con, we assume that the total deviations from the unity line, s
2
dif , result from
both the intra-individual variability and the regression uncertainty, such that s2dif ¼ s2con þ 2 s2reg .
The value of s2dif is estimated using the mean squared difference, which would be equivalent to the
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unbiased variance of Zp, if Z were zero. Using the average s2reg , we can estimate s
2
con according to
s2con ¼
1
Ccon
XCcon
p¼1
Z2p  2 s2reg ð12Þ
Please see S2 File for further details. For the B6 mice analysed here, s2con ¼ 0:046, giving two-sigma
of 2scon = 0.430, as a difference in the log domain. This corresponds to a 53% increase or a 35%
decrease in facility, for a given pair. The green outer ellipses in Fig 6a show the uncertainty includ-
ing scon. For each of the pairs, the outer ellipses cross the unity line, and thus the facilities for the
two eyes from each mouse are not signiﬁcantly different from one another when accounting for
intra-individual variability. Analysing these data in terms of the difference in log-transformed
facility between contralateral eyes yields Z ¼ 0:075 0:160, which is not signiﬁcantly different
from zero. The red line in the ﬁgure shows Z , and the grey shaded area shows the conﬁdence
interval on Z (Z MEZ ;95), which overlaps the blue unity line, and thus Z is not statistically dif-
ferent from zero. See Table 1 for a summary of the key statistical parameters.
Although variability between contralateral eyes appears to be fairly large, it is still possible
to use the system to conclusively measure differences in facility. To verify this, 12 pairs of eyes
were perfused intracamerally with 10 nM 3,7-dithia prostaglandin E1 (PDA205) or vehicle con-
trol in DBG. PDA205 (Allergan Inc., Irvine CA) was stored as a lyophilised powder at −80°C,
dissolved in ethanol as a 10mM stock solution, stored at −20°C and protected from light at all
Fig 6. Comparison of facility for paired eyes using ‘Paired Facility plots’. Each data point represents one individual, with the log-transformed facility of
each eye defining the co-ordinates. Filled ellipses indicate 95% confidence intervals from the regression fitting of Eq 9 (1.96sreg) and outer ellipses indicate
additional uncertainty due to intra-individual variability (scon). Inset: facility in nl/min/mmHg. Unity line is shown in blue. Red line shows average difference Z ,
with its conﬁdence intervals in grey. (a) Untreated contralateral pairs. No pairs exhibited a signiﬁcant difference between contralateral eyes when accounting
for uncertainty. (b) Effect of PDA205 treatment compared to control eyes. A signiﬁcant increase in the facility following treatment is observed, although there
is considerable variability (s2tre) introduced by the drug.
doi:10.1371/journal.pone.0150694.g006
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times. Working stock was made up daily by diluting the stock solution in DBG. The control
eye received DBG with an equivalent concentration of vehicle (17 μM ethanol). PDA205 is an
EP4 agonist and has been shown previously to increase outflow facility in enucleated mouse
eyes [11], enucleated human eyes [44] and living monkey eyes [45].
The results of the PDA205 experiments are presented as a paired facility plot in Fig 6b. The
x-axis is the log-transformed facility of the control eyes, and the y-axis is the log-transformed
facility of the treated eyes. For data points lying above the blue unity line, an increased facility
was measured in response to the treatment. Although PDA205 is known to increase outflow
facility, of the 12 pairs examined here, only 5 pairs independently exhibited a significant differ-
ence in facility in response to treatment (green ellipses did not cross the unity line). However,
all pairs did show some increase in facility, and thus a statistically significant increase was
observed overall. For these data, Z ¼ 0:446 0:212ð0:487Þ. This gives a proportional change
of D ¼ 1:56 = 1:24ð1:63Þ. These data imply an overall percentage increase in facility of 56%
in response to PDA205 (p = 0.0008). The two-sigma on the percentage facility increase for indi-
vidual pairs, however, spanned a wide range from -4% to 154%. One could thus conclude from
these data that PDA205 increases outﬂow facility on average, but that the effect of the drug var-
ies considerably between individuals.
Non-linearity parameter. For the 10 untreated pairs, the power law exponent, β was not
correlated between paired eyes (r = 0.246). However, when one case in which the maximum
pressure was less than 9mmHg (and thus βmay not be well characterised) was removed, the
correlation coefficient increased to r = 0.799 (p = 0.0097), implying that the pressure-depen-
dence of facility may be paired between contralateral eyes. Applying Eq 12 to the nine β values
yielded a two-sigma of 2scon,β = 0.322, approximately half the average value for the population.
Analysis of unpaired measurements
In some cases, it is not possible to perform paired measurements between contralateral eyes.
In order to demonstrate the processing for unpaired data, the PDA205 data set was also ana-
lysed as if the control and treated eyes were obtained from different individuals. Fig 7 shows a
modified form of a violin plot of the data, which we refer to as a ‘cello’ plot. The individual Cr
values for each eye are shown by the markers, with the 95% confidence intervals on the regres-
sion uncertainty shown by the error bars. As described above, there will be an additional
uncertainty on Cr related to the cannulation, but we cannot quantify this uncertainty indepen-
dent of the population variability, and it is therefore not indicated in the cello plot. The shaded
region in the background indicates the predicted lognormal distribution of Cr, as described by
the calculated Cr
 and sCr , and the width is scaled such that area of each shaded region is equal
for the control and treated eyes. The geometric mean Cr
 is indicated by the thick central
white line, and the thin white lines indicate two-sigma, within which 95% of eyes from this
population are expected to lie. The grey area in the centre of the data set indicates the 95%
conﬁdence interval on Cr
. As compared to a box plot, the cello plot shows all individual data
Table 1. Summary of the results of the untreated and PDA205 analyses. All terms are dimensionless. p ðZ ¼ 0Þ is the probability that the observed Z is
not signiﬁcantly different from zero, according to the weighted t-test described in S2 File.
Case Z MEZ ;95 2stre % D MED ;95 s2tre pðZ ¼ 0Þ
Untreated Pairs 0.075 0.160 - 8 1.08 1.17 - 0.3159
PDA205 Paired 0.446 0.212 0.487 56 1.56 1.24 1.63 0.0007
PDA205 Unpaired 0.440 0.322 0.543 55 1.55 1.38 1.72 0.0100
doi:10.1371/journal.pone.0150694.t001
Measurement of Outflow Facility Using iPerfusion
PLOSONE | DOI:10.1371/journal.pone.0150694 March 7, 2016 21 / 29
points and their uncertainty, as well as the predicted distribution and the conﬁdence interval
on the mean, providing a complete overview of the data. Consistent with the paired analysis,
the cello plot in Fig 7 shows an increase in Cr in response to treatment with PDA205 using
unpaired analysis.
The statistics for the unpaired analysis yield a similar proportional increase in response to
PDA205 to that calculated with the paired analysis, D ¼ 1:55 (see Table 1). However, the CI
on the mean proportional change increases signiﬁcantly for the unpaired analysis, as evidenced
byMED ;95 increasing from 1.24 to 1.38. Correspondingly, the calculated p-value is more than
an order of magnitude greater when the data were analysed as unpaired relative to paired,
although both p-values would still be considered signiﬁcant.
PDA205 has a relatively large facility effect, however, and thus treatments having smaller
effect sizes may not achieve sufficient statistical power to be detected by unpaired analysis with-
out using prohibitively large number of animals. Note also that the value of s2tre increases, but
by relatively little, from 1.63 for paired analysis to 1.72 for unpaired analysis, indicating that
both methods predict a similar variability in the treatment effect.
Recommendations
The measurement of outflow facility in mice, or indeed any animal, is technically challenging.
A number of different approaches have been reported in the literature for acquiring pressure
and flow data during ocular perfusions, to which a model is fitted in order to estimate the facil-
ity. Subsequently, statistical analysis is carried out on the facilities of treated and control eyes,
in order to establish whether observed trends are significant. Based on findings from this study,
Fig 7. Comparison of facility for unpaired eyes using the ‘Cello plot’. Unpaired analysis of facility for
PDA205 treated and control eyes. Each data point shows the reference facility,Cr, with the error bars
showing 95% confidence intervals from the regression fitting of Eq 10 (1.96sreg). Shaded regions show best
estimates of the sample distributions, with the geometric mean and two-sigma shown by the thick and thin
horizontal lines respectively. Dark central bands show 95%CI on the mean values.
doi:10.1371/journal.pone.0150694.g007
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we make the following recommendations regarding measurement of outflow facility in enucle-
ated mouse eyes.
System validation. In order to analyse the uncertainty, one must first establish that the
pressure and flow can be measured with sufficient accuracy and resolution in the physiological
range of interest. As the facility is the main parameter of interest, acceptable facility measure-
ments should be demonstrated in the appropriate range, which can be done using glass
capillaries. Similar validation would be necessary for techniques to measure other parameters
in live animals, such as AH secretion, episcleral venous pressure or unconventional outflow.
Steady state condition. Due to the compliant response of the eye to a change in pressure
or flow, an accurate measurement of facility can only be acquired when the system has reached
steady state. An objective steady state condition should be defined and its implications for the
measurement of facility should be discussed.
Pressure steps. The pressure steps used in the present protocol have been selected so as to
provide high resolution around the physiological range of pressure drops across the outflow
pathway (8mmHg), as well as data at elevated intraocular pressures. Both the range and
number of pressure steps are arbitrary and can be tailored to a particular experiment, but
should be held constant as much as possible for comparing cases within a given experiment.
Increasing the number of pressure steps improves confidence intervals on the facility estimate
and thereby effectively increases measurement accuracy, but also increases the duration of the
experiment.
Model fitting. The present results demonstrate that the flow-pressure relationship is non-
linear in enucleated mouse eyes, and the standard linear fit (and assumption of a facility that is
independent of pressure) is therefore not appropriate. Applying a linear fit leads to the appear-
ance of pressure-independent outflow, but no such outflow is present in enucleated mouse
eyes. Furthermore, using the linear model to estimate facility, even when the flow-pressure
relationship appears relatively linear, may result in errors up to 250%. For these reasons, we
recommend using the power law model proposed in Eq 9. We also advocate showing sample
flow-pressure relationships, along with the fit and 95% confidence bounds, to demonstrate the
quality of the perfusion data.
Statistical distribution. The present data have shown that facility is better described by a
lognormal distribution than the commonly assumed normal distribution. In order to make use
of the standard statistical tools that require normality, the log-transformed facility should be
obtained by fitting Eq 10 to the flow-pressure data, and all statistical analysis should be con-
ducted in the log domain.
Data analysis. Ocular perfusion measurements, particularly those in mouse eyes, include
several sources of uncertainty that may vary between individual samples. Additionally, the
average treatment size and variability in the treatment effect are of importance. For these rea-
sons, we developed statistical tools, including the weighted t-test, which can be applied to any
perfusion data, and introduced the paired XY plot and cello plot. Use of the data analysis meth-
ods reported here would improve the transparency of data in future studies and enable
improved comparability between studies.
Negative results. It is not possible to conclude from an experiment that a given experi-
mental condition has no effect. However, using the statistics developed in this paper, an appro-
priate CI on Z can be determined, from which one can obtain an estimate of the minimum
effect size that could have been detected. For example, in the paired analysis of the PDA205
data set,MEZ ;95 ¼ 0:214. This implies that, for the twelve pairs we measured, the minimum
net change we would have been able to statistically resolve would be ±0.214, a fold change of
approximately ±20%.
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Limitations
A number of outstanding issues remain in the development of methods to accurately measure
outflow facility in mice. One issue is that, when using a single needle to perfuse with com-
pounds via the anterior chamber, it is unclear whether the compound has acted on the entire
outflow pathway before facility measurements are initiated. Considering an average B6 mouse
with a facility of 6 nl/min/mmmHg at a physiological pressure drop of 8mmHg, it would take
more than two hours to turnover the anterior chamber volume, which is approximately 6 μl
[21]. This problem is exacerbated by segmental outflow that may deliver the compound non-
uniformly to the trabecular meshwork [46, 47]. Variability in the uniformity of drug delivery
may elevate the apparent value of s2tre and increase the number of mice required to achieve sufﬁ-
cient statistical power. A possible solution is to fully exchange the contents of the anterior
chamber with the treatment solution prior to the start of the stepping protocol, but this would
require a second perfusion needle, which is technically challenging and would likely introduce
additional variability into the facility measurements. Alternatively, it may be possible to pre-
treat the eyes prior to the perfusion either topically or intracamerally, assuming that this deliv-
ery did not interfere with the perfusion and was compatible with the time scale of the facility
effect.
A second question is the mechanism of the pressure-dependent increase in outflow facility.
In other species such as primates, outflow facility typically decreases with increasing pressure
[40], which has been attributed to pressure-induced collapse of Schlemm’s canal [39]. If perfu-
sions are carried out ex vivo via the anterior chamber, however, the resulting pressure differ-
ence generated across the iris exerts traction on the outflow pathway and increases outflow
facility; this phenomenon is known as ‘anterior chamber deepening’ [48] and is an experimen-
tal artefact that can be overcome by perfusing via the posterior chamber or by creating a shunt
across the iris (iridectomy) [41]. The eyes in this study were perfused via the anterior chamber
without an iridectomy, and thus it is possible that anterior chamber deepening may have con-
tributed to the pressure-dependent increase in outflow facility and to the non-linearity of the
flow-pressure relationship. It is conceivable that pressure dependence in both the conventional
and unconventional outflow pathways could contribute to the observed non-linearity. How-
ever, it is not possible to distinguish reliably between alternative anatomical routes based on
perfusion data alone. Unconventional outflow is commonly regarded to be relatively pressure
insensitive [22, 49] and therefore increasing unconventional outflow facility seems an unlikely
candidate for the observed pressure-dependent increase in total outflow facility.
Finally, we accept that as the perfusions were conducted on post-mortem enucleated eyes,
the current experiments do not fully capture the mechanisms that may influence outflow facil-
ity regulation in vivo. This includes the potential effect of innervation, vascular regulation or
other local or systemic factors that may influence outflow facility. As discussed below, in vivo
measurements have their own limitations regarding other aspects of AH dynamics that may
change during the perfusion and thereby complicate measurements of facility in living animals,
but some of these in vivo limitations may be overcome using the iPerfusion system. Studies to
establish in vivo techniques using iPerfusion are currently underway.
Implications for in vivo perfusions
The main advantage of perfusing enucleated eyes, relative to eyes maintained in vivo or in situ,
is control over the parameter space. In enucleated eyes, the variables Qin, Pe and Q0 in Eq 1 are
zero, and the temperature, hydration state of the eye and external pressure can be accurately
controlled by fully immersing the eye in isotonic saline. Conversely, for in vivo experiments,
Qin and Q0 are unknown, the downstream pressure in the conventional outflow pathway, Pe, is
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determined by episcleral venous pressure, and the hydration state of the eye is harder to con-
trol. Furthermore, anaesthesia may alter these parameters during a perfusion. For in situmea-
surements in euthanised animals, the values of Qin, Q0 and Pe would decay to zero eventually,
but the time scales of this decay are unknown and would likely differ between parameters.
Although a range of complementary methods may be used to estimate these variables, the com-
pound uncertainties in each variable would weaken confidence on the estimates on the final
parameters. These added complications can be justified by the fact that ultimately in vivo perfu-
sions are a direct measurement of the entire system of ocular fluid dynamics, rather than a dis-
connected component as measured ex vivo. However, the present findings suggest that some of
the common assumptions made in the analysis of in vivo data may not be appropriate.
In living animals, AH secretion,Qin, pressure-independent outflow,Q0, and episcleral venous
pressure, Pe, are all expected to be non-zero, and these terms would need to be added to an anal-
ogous form of Eq 9 that is appropriate for in vivo pefusions. If one assumed that Q0, Qin and Pe
were independent of both time and pressure, then a potential model for the flow-pressure rela-
tionship in living mouse eyes would be given byQ Pð Þ ¼ Cr PPePrPe
 b
P  Peð Þ þ Q0  Qin, where
the total pressure-independent ﬂow in the system is Q0 − Qin, and would be negative indicating
a net ﬂow from the eye into the perfusion system at P = Pe. Due to the non-linearity of facility,
Qin − Q0 could not be accurately estimated by extrapolation, but would need to be measured
directly when P = Pe. Additionally, knowledge of Pe is necessary to estimate C, which would not
be the case if C was independent of pressure. Methods have been reported to estimate Pe and
Qin in mouse eyes, but the accuracy of such measurements requires validation [12, 13, 21].
An additional and considerable complication in the context of in vivo perfusions is the
change in IOP over time under anaesthesia [31, 50–52]. Episcleral venous pressure is directly
correlated with mean arterial pressure [53] and will thus decrease over time, as well as being
influenced by topical anaesthesia [54]. AH secretion, Qin, is also reduced under anaesthesia
[55], despite its mechanism being predominantly independent of pressure. The change of these
variables in time, introduces additional uncertainty in the estimation of outflow facility. The
two-step constant pressure perfusion commonly used in monkeys to account for time-varying
parameters inherently assumes a facility that is independent of pressure [24], and so may not
be completely appropriate if in vivomouse eyes exhibit a non-linear flow-pressure relationship,
as observed ex vivo.
Conclusions
In this study, we described iPerfusion, a constant pressure perfusion system that provides faster
and more accurate measurements of outflow facility in enucleated mouse eyes, relative to per-
fusion systems previously described in the literature. We fully characterised the iPerfusion sys-
tem in the physiological range of facility values relevant for mice, including in vitro tests and ex
vivo studies. We developed a statistical analysis and the weighted t-test to account for uncer-
tainties in the perfusion measurements and in the estimation of facility, and devised graphical
formats to present the data in a manner that appropriately displays the uncertainty and spread
in the measurements.
Using iPerfusion, we demonstrated that there is negligible pressure-independent outflow in
fully hydrated enucleated eyes from young B6 mice. Using a 9-step perfusion protocol, we
showed that the flow-pressure relationship was consistently non-linear and as a consequence,
inappropriate application of a linear model to the data led to considerable overestimation of
outflow facility. In contrast to the linear model, the flow-pressure relationship was well
described by a simple power law model that captured the pressure-dependence of outflow
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facility. Comparing the linear and power law models revealed that the appearance of pressure-
independent outflow when analysed using the linear model is most likely attributable to the
non-linearity in the flow-pressure relationship and the inappropriate assumption of pressure-
independent outflow facility.
Analysis of 66 mice revealed that baseline facility is better described by a lognormal distribu-
tion than a normal distribution. Hence, statistical analysis of facility should be carried out in
the log domain, by using log-transformed values. The distribution of baseline facility values
spanned nearly a 6-fold range, but facility was relatively tightly correlated between contralateral
eyes. This large variability between individuals was not attributable to any apparent experimen-
tal condition, and given the correlation between contralateral eyes, it appears that this spread
may have a physiological origin. As IOP variability within the B6 population has been reported
to be 14.6 ± 5.2 (mean ± 2SD) [56], such a large spread in facility is unexpected and may sug-
gest that facility is somehow regulated to maintain a fairly constant IOP, despite other systemic
variables that may affect AH dynamics. Further research is needed to investigate the basis of
the wide distribution of facility between individuals, but the fact that the spread is so large
emphasises the advantage of using a paired experimental design.
With minor modifications, the iPerfusion system may be translated to other species and to
in vivo ocular perfusion, as well as perfusion of other biofluidic systems.
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